Jess Roper's Insider Trades & SAST Disclosures
Jess Roper's most recent trade in Revelation Biosciences Inc was a trade of 181 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on Feb. 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jess Roper.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Revelation Biosciences Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 3.87 per share. | 11 Feb 2025 | 181 | 183 | - | 3.9 | 700 | Common Stock |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 512,821 | 554,596 | - | - | Restricted Stock Unit | |
| Revelation Biosciences Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 6,356 | 6,356 | - | - | Stock Option (Right to Buy) | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2022 | 41,775 | 41,775 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jess Roper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Apr 2022 | 345 | 0 | - | - | Series G Preferred Stock | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 138,000 | 138,000 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2021 | 111,337 | 111,337 | - | - | Stock Appreciation Right | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2020 | 20,000 | 260,397 | - | - | Restricted Stock Unit | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 187,378 | 187,378 | - | - | Stock Option (right to buy) | |
| Biolase Inc | Jess Roper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2020 | 165,245 | 240,397 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges